Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society

BACKGROUND: Based on the Japan Adjuvant Study Group of Pancreatic Cancer-01 results, S-1 adjuvant chemotherapy has been the standard in resected pancreatic ductal adenocarcinoma (PDAC) patients in Japan and elsewhere, initiated within 10 weeks after surgery. To assess the clinical impact of this tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomimaru, Yoshito, Eguchi, Hidetoshi, Shimomura, Yoshimitsu, Kitamura, Tetsuhisa, Inoue, Yosuke, Nagakawa, Yuichi, Ohba, Akihiro, Onoe, Shunsuke, Unno, Michiaki, Hashimoto, Daisuke, Kawakatsu, Shoji, Hayashi, Tsuyoshi, Higuchi, Ryota, Kitagawa, Hirohisa, Uemura, Kenichiro, Kimura, Yasutoshi, Satoi, Sohei, Takeyama, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article―Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366324/
https://www.ncbi.nlm.nih.gov/pubmed/37329351
http://dx.doi.org/10.1007/s00535-023-01988-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366324/
https://www.ncbi.nlm.nih.gov/pubmed/37329351
http://dx.doi.org/10.1007/s00535-023-01988-7

Ejemplares similares